{"ok":true,"nota":{"id":"fa8d27daddad21c5","slug":"en-espana-los-trasplantes-combinados-de-corazon-con-otro-organo-tienen-fa8d27","titulo":"En España, los trasplantes combinados de corazón con otro órgano tienen buena supervivencia a cinco años","resumen":"Revisaron retrospectivamente el registro español de trasplantes de corazón entre 1998 y 2024, excluyendo niños. Compararon trasplantes solo de corazón con los combinados con riñón, pulmón, hígado o células madre.","fuente":"zenodo","fuenteNombre":"Zenodo · Investigación abierta","color":"#1682d4","autor":"López-Vilella, R., González-Costello, J., González-Vílchez, F.","url":"https://doi.org/10.1016/j.healun.2026.01.018","imagen":"/hoy/portada/fa8d27daddad21c5","tema":"salud","subtemas":["trasplante de corazón","trasplante combinado","supervivencia","registro médico","cirugía"],"entidades":["España","Registro Español de Trasplante Cardíaco"],"formato":"dato","entretenimiento":false,"pubTs":"2026-10-19T06:49:28.000Z","indexTs":"2026-10-21T05:32:19.019Z","hash":"798706428be064dc385e39e83f05220bc73bff5eccdfb0260f0967852be20016","tsa":{"time":"Oct 21 05:33:04 2026 GMT","provider":"freetsa.org","sobre":"sello"},"stats":{"views":0,"likes":0,"clicks":0,"dwell":0},"tipo":"normal","registro":"hallazgo","porQueImporta":"Hay pacientes que necesitan dos órganos a la vez, y saber cuánto sobreviven ayuda a decidir si la operación vale la pena. En el estudio, los combinados de corazón con riñón o hígado mostraron tasas de supervivencia altas a 30 días. Esto importa para quien espera en lista de trasplante, porque el sistema de salud tiene que decidir cuántos recursos destina a estas cirugías complejas. Pero los números de cinco años varían bastante según el tipo de combinación.","quienFirma":"Registro Español de Trasplante Cardíaco (España)","confianza":"revisado","consulta":null},"sello":{"hash":"798706428be064dc385e39e83f05220bc73bff5eccdfb0260f0967852be20016","sello":"be16351e3798ea1ba5f27687eb78c7619f4df5d3ea0ad158585465f074c3575f","beacon":{"drand":{"cadena":"8990e7a9aaed2ffed73dbd7092123d6f289930540d7651336225dc172e51b2ce","ronda":6570992,"aleatorio":"f264da7b048e9cf41e4b5970a796c574d6487c881a0d04375c140c848a8228db","tiempo":"2026-10-21T05:33:00.000Z"},"nist":{"cadena":2,"pulso":1992701,"salida":"0CE79E7721AED6EB4B6E297712C3BA73E0C25CE80DE0CADB9F9A4E5E4E8E695832F0C44FE75F6028A4FB1015CC9469A6E5F307FEBACFB473031E6B5CA59A96AE","tiempo":"2026-10-21T05:32:00.000Z"},"noAntes":"2026-10-21T05:33:00.000Z"},"verificacion":{"drand":true,"nist":true},"tsa":{"time":"Oct 21 05:33:04 2026 GMT","provider":"freetsa.org","sobre":"sello"},"original":{"titulo":"Combined heart and other organ transplants in Spain: Current review of clinical outcomes. COMBI Study","descripcion":"Background Combined heart transplantation (HTx) with other organs is an established intervention when both organs fail simultaneously or when a noncardiac organ fails after HTx. This study aimed to describe the Spanish experience with this transplant modality and to analyze survival outcomes. Methods This is a retrospective study based on the Spanish Heart Transplant Registry (1998-2024). Pediatric HTx and patients with previous transplants of other organs were excluded. Patients were classified into isolated HTx (n = 6663), simultaneous combined HTx (n = 147; kidney:60; lung:71; liver:16), and delayed combined HTx (n = 110; kidney:72; hematopoietic stem cells [HSC]:27; liver:10; lung:1). Combined HTx accounted for 3.9% of the total. Results For simultaneous combined procedures, 30-day survival rates were: HTx+kidney: 84%; HTx+liver: 88%; HTx+lung: 73% (p = 0.034); 5-year survival rates ","pubDate":"2026-10-19T06:49:28Z","url":"https://doi.org/10.1016/j.healun.2026.01.018"},"indexado":"2026-10-21T05:32:19.019Z"}}